US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cuprina Holdings (Cayman) Limited

7.85

+0.12001.55%

Volume:140.02K

Turnover:1.11M

Market Cap:168.38M

PE:-123.57

High:7.97

Open:7.70

Low:7.70

Close:7.73

Loading ...

Overview Company News Filings

Cuprina Signs Agreement to Market Medical Maggots for Debridement Therapy in US

MT Newswires Live

Cuprina Holdings Appoints Dr. Ronald Sherman as Medical and Scientific Director, Enhancing Leadership in Maggot Debridement Therapy

Cuprina Appoints DR. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-Approved Medical Maggot License for U.S. Market

THOMSON REUTERS

Cuprina Holdings Announces Resignation of CTO Baptista Carl Marc Effective June 2025

Cuprina Provides Update on Research Studies With Three Leading Education Institutes

THOMSON REUTERS

Cuprina Holdings Announces New Clinical Study on Bullfrog Collagen Peptides for Advanced Wound Care and Cosmeceutical Applications

Cuprina Holdings (Cayman) Ltd trading resumes

Cuprina MENA Secures Exclusive License for Medicinal Leeches in GCC Countries and Completes Lab for Chronic Wound Therapy in Saudi Arabia

Cuprina Holdings (Cayman) Ltd - Cuprina Mena Seeking Regulatory Approvals to Sell Therapy in Mena Region

THOMSON REUTERS

Cuprina Completes Lab Able to Supply Medifly Chronic Wound Therapy Across Mena Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

THOMSON REUTERS

Cuprina Holdings (Cayman) Ltd - Cuprina Mena Secures Exclusive Rights From Biopharm UK Ltd to Sell Medicinal Leeches in GCC Countries

THOMSON REUTERS

Cuprina Completes Sale of Additional 450,000 Class A Shares After Full Exercise of Over-Allotment Option

MT Newswires Live

Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection With Initial Public Offering

THOMSON REUTERS

Cuprina Obtains ISO Certification, License for Singapore IVF Facility

MT Newswires Live

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration With Ferti-Craft Pte Ltd.

THOMSON REUTERS

Cuprina Closes $12 Million IPO

MT Newswires Live

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

THOMSON REUTERS

Cuprina Shares Drop on Nasdaq Debut After Opening at Above IPO Price

MT Newswires Live

Cuprina Prices Initial Public Offering

MT Newswires Live

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 Million Initial Public Offering

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CUPR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUPR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUPR\",,,,,undefined,":{"symbol":"CUPR","market":"US","secType":"STK","nameCN":"Cuprina Holdings (Cayman) Limited","latestPrice":7.85,"timestamp":1753289269181,"preClose":7.73,"halted":0,"volume":140024,"delay":0,"floatShares":7364999,"shares":21450000,"eps":-0.063525,"marketStatus":"Trading","change":0.12,"latestTime":"07-23 12:48:03 EDT","open":7.7,"high":7.97,"low":7.7,"amount":1105539.608592,"amplitude":0.034929,"askPrice":7.9,"askSize":286,"bidPrice":7.84,"bidSize":398,"shortable":3,"etf":0,"ttmEps":-0.063525,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753300800000},"marketStatusCode":2,"adr":0,"listingDate":1724644800000,"exchange":"NASDAQ","adjPreClose":7.73,"preHourTrading":{"tag":"盘前","latestPrice":7.9,"preClose":7.73,"latestTime":"09:28 EDT","volume":534,"amount":4228.830105,"timestamp":1753277305069},"postHourTrading":{"tag":"盘后","latestPrice":7.46,"preClose":7.73,"latestTime":"19:59 EDT","volume":5472,"amount":40935.6524,"timestamp":1753228752631},"volumeRatio":0.73444},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUPR\",,,,,undefined,":{"symbol":"CUPR","floatShares":7364999,"roa":"-61.75%","roe":"--","lyrEps":-0.063525,"volumeRatio":0.73444,"shares":21450000,"dividePrice":0,"high":7.97,"amplitude":0.034929,"preClose":7.73,"low":7.7,"week52Low":3.51,"pbRate":"-48.24","psRate":"4452.02","week52High":8,"institutionHeld":0,"latestPrice":7.85,"committee":0.163743,"eps":-0.063525,"divideRate":0,"volume":140024,"delay":0,"ttmEps":-0.063525,"open":7.7,"prevYearClose":4,"prevWeekClose":7.57,"prevMonthClose":5.86,"prevQuarterClose":5.86,"fiveDayClose":7.5,"twentyDayClose":5.8,"sixtyDayClose":4.74},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUPR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553477068","title":"Cuprina Signs Agreement to Market Medical Maggots for Debridement Therapy in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2553477068","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553477068?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:59","pubTimestamp":1753106385,"startTime":"0","endTime":"0","summary":"Cuprina  said Monday it has signed an agreement to acquire the right to market medical maggots for use in debridement therapy to treat chronic wounds in the US.The agreement was signed with Ronald Sherman, who holds a 2004 US Food and Drug Administration clearance to market Lucilia sericata maggots, giving Cuprina the right to manufacture, sell, use, and distribute the medical maggots and associated dressings for maggot debridement therapy, according to a statement.Sherman will join the company as medical and scientific director in September, Cuprina said.Cuprina also said it is updating a submission to the FDA to seek approval for the use of another species of medical maggots, Lucilia cuprina, and could receive marketing clearance within 90 business days.Price: 7.55, Change: -0.02, Percent Change: -0.26","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUPR","BK4198"],"gpt_icon":0},{"id":"2553747235","title":"Cuprina Holdings Appoints Dr. Ronald Sherman as Medical and Scientific Director, Enhancing Leadership in Maggot Debridement Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2553747235","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553747235?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:00","pubTimestamp":1753102827,"startTime":"0","endTime":"0","summary":"Cuprina Holdings Appoints Dr. Ronald Sherman as Medical and Scientific Director, Enhancing Leadership in Maggot Debridement Therapy. Cuprina Holdings  Ltd. has appointed Dr. Ronald A. Sherman as Medical and Scientific Director, effective September 2025. Dr. Sherman, known for his work in medical maggot therapies, will provide clinical leadership and guidance on bio-therapeutics, and assist in developing a training framework for clinicians. Cuprina is updating its FDA submission for Lucilia cuprina maggots, aiming to secure a second U.S. FDA clearance for maggot debridement therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  Ltd. published the original content used to generate this news brief via GlobeNewswire  on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL1CHhy5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","CUPR","BK4588","BK4112","LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","IE00B64PRP62.GBP","BK4198","BK4585"],"gpt_icon":0},{"id":"2553472376","title":"Cuprina Appoints DR. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures  FDA-Approved Medical Maggot License for U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2553472376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553472376?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:00","pubTimestamp":1753102801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nTUA8TF2DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUPR","BK4198"],"gpt_icon":0},{"id":"2548907058","title":"Cuprina Holdings Announces Resignation of CTO Baptista Carl Marc Effective June 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548907058","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548907058?lang=en_us&edition=fundamental","pubTime":"2025-07-01 18:16","pubTimestamp":1751364960,"startTime":"0","endTime":"0","summary":"Cuprina Holdings  Ltd. has announced the resignation of Baptista Carl Marc as Director and Chief Technology Officer, effective June 30, 2025. Mr. Baptista is stepping down to pursue other business opportunities, and his departure was not due to any disagreement with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL2pw0yx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2547099340","title":"Cuprina Provides Update on Research Studies With Three Leading Education Institutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2547099340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547099340?lang=en_us&edition=fundamental","pubTime":"2025-06-30 20:00","pubTimestamp":1751284802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nTUABQXRQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2547096241","title":"Cuprina Holdings Announces New Clinical Study on Bullfrog Collagen Peptides for Advanced Wound Care and Cosmeceutical Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2547096241","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547096241?lang=en_us&edition=fundamental","pubTime":"2025-06-30 19:55","pubTimestamp":1751284545,"startTime":"0","endTime":"0","summary":"Cuprina Holdings Announces New Clinical Study on Bullfrog Collagen Peptides for Advanced Wound Care and Cosmeceutical Applications. Cuprina Holdings  Ltd. has announced progress on several research studies in collaboration with prominent educational institutes focusing on the development of innovative biomedical and cosmeceutical products. The company is exploring the use of collagen peptides derived from American bullfrog skin for diverse applications, including 3D printable wound care dressings and microneedling patches. These studies are conducted in collaboration with the National University of Singapore and the Singapore Institute of Technology. Cuprina is also investigating the production of superior powdered bullfrog collagen peptides for cosmeceuticals. Results from these studies are anticipated to enhance product offerings in wound care and beauty sectors, with ongoing testing to determine their efficacy. Further updates will be provided as research progresses and results beco","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL5JT1nv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2542339352","title":"Cuprina Holdings (Cayman) Ltd trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2542339352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542339352?lang=en_us&edition=fundamental","pubTime":"2025-06-10 00:10","pubTimestamp":1749485439,"startTime":"0","endTime":"0","summary":"12:06 EDT Cuprina Holdings (CUPR) (Cayman) Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cuprina-holdings-cayman-ltd-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cuprina-holdings-cayman-ltd-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2540267063","title":"Cuprina MENA Secures Exclusive License for Medicinal Leeches in GCC Countries and Completes Lab for Chronic Wound Therapy in Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2540267063","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540267063?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038411,"startTime":"0","endTime":"0","summary":"Cuprina MENA Secures Exclusive License for Medicinal Leeches in GCC Countries and Completes Lab for Chronic Wound Therapy in Saudi Arabia. Cuprina MENA Co. Ltd, a 49%-owned associate of Cuprina Holdings  Ltd, has completed the establishment of a laboratory in Saudi Arabia designed to manufacture MEDIFLY maggot debridement therapy for chronic wound treatment. This new facility will supply the therapy throughout the Middle East and North Africa region. Additionally, Cuprina MENA has acquired exclusive rights to market medicinal leeches in the Gulf Cooperation Council countries, a treatment increasingly used for medical conditions such as venous congestion and to enhance tissue healing post-surgery. These strategic advancements are expected to broaden Cuprina's market presence in the MENA and GCC regions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9ZNyrM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","LU2210149790.SGD","BK4198","IE00B3QW5Z07.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BKPKM429.USD","CUPR","BK4585"],"gpt_icon":0},{"id":"2540775063","title":"Cuprina Holdings (Cayman) Ltd - Cuprina Mena Seeking Regulatory Approvals to Sell Therapy in Mena Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775063?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA2VH020:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2540063956","title":"Cuprina Completes Lab Able to Supply Medifly Chronic Wound Therapy Across Mena  Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2540063956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540063956?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA2VH020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2540063076","title":"Cuprina Holdings (Cayman) Ltd - Cuprina Mena Secures Exclusive Rights From Biopharm UK Ltd to Sell Medicinal Leeches in GCC Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2540063076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540063076?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA2VH020:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2534115251","title":"Cuprina Completes Sale of Additional 450,000 Class A Shares After Full Exercise of Over-Allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2534115251","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534115251?lang=en_us&edition=fundamental","pubTime":"2025-05-09 01:33","pubTimestamp":1746725580,"startTime":"0","endTime":"0","summary":"Cuprina  said Thursday it has completed the sale of 450,000 additional Class A shares after the underwriter fully exercised its over-allotment option.The shares were sold at the IPO price of $4.00 each, before underwriting discounts, the company said.With this, the company's total gross proceeds reached $13.8 million, which includes $12 million raised earlier through the initial public offering, it added.Shares of the company were down nearly 13% in recent trading.Price: 4.62, Change: -0.68, Percent Change: -12.83","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2534151732","title":"Cuprina Holdings Announces Closing of Underwriter’s  Over-Allotment Option in Connection With Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2534151732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534151732?lang=en_us&edition=fundamental","pubTime":"2025-05-09 01:05","pubTimestamp":1746723900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nTUA1FZ6RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUPR","BK4198"],"gpt_icon":0},{"id":"2533534570","title":"Cuprina Obtains ISO Certification, License for Singapore IVF Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2533534570","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533534570?lang=en_us&edition=fundamental","pubTime":"2025-05-05 23:42","pubTimestamp":1746459744,"startTime":"0","endTime":"0","summary":"Cuprina (CUPR) said Monday it completed construction of its in-vitro fertilization media production facility in Singapore and obtained ISO 13485 certification and a dealer license for the site on Apri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4198","CUPR","BK4121","BK4082","ISO"],"gpt_icon":1},{"id":"2533743533","title":"Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration With Ferti-Craft Pte Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2533743533","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533743533?lang=en_us&edition=fundamental","pubTime":"2025-05-05 22:40","pubTimestamp":1746456000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA8BXYZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUPR","BK4198"],"gpt_icon":0},{"id":"2526169422","title":"Cuprina Closes $12 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2526169422","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526169422?lang=en_us&edition=fundamental","pubTime":"2025-04-11 23:24","pubTimestamp":1744385059,"startTime":"0","endTime":"0","summary":"Cuprina  said Friday it closed its initial public offering of 3 million class A ordinary shares at $4 a piece for gross proceeds of $12 million.The biomedical and biotechnology company said it plans to use the net proceeds for expansion into new markets, research and development, building brand awareness, investing in equipment and infrastructure, and working capital and general corporate purposes.Price: 4.11, Change: -0.04, Percent Change: -0.96","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUPR"],"gpt_icon":1},{"id":"2526911216","title":"Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2526911216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526911216?lang=en_us&edition=fundamental","pubTime":"2025-04-11 23:07","pubTimestamp":1744384020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nTUA7BZ1QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUPR"],"gpt_icon":0},{"id":"2526519161","title":"Cuprina Shares Drop on Nasdaq Debut After Opening at Above IPO Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2526519161","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526519161?lang=en_us&edition=fundamental","pubTime":"2025-04-11 00:50","pubTimestamp":1744303819,"startTime":"0","endTime":"0","summary":"Cuprina  stock dropped more than 7% on its Nasdaq debut Thursday, giving away gains from early in the day.The Singapore-based biotechnology company priced an upsized $12 million initial public offering of 4 million class A ordinary share, up from initial plan of 3.75 million shares, at $4 each.Cuprina shares opened at $4.40 just after 11:30 a.m. ET, up 10%, and quickly touched an intra-day high of $4.79 before dropping.The company has granted underwriters an additional 450,000 shares as overallotment option. If the option is fully exercised, gross proceeds are expected to reach $13.80 million.Cuprina plans to use net proceeds to fund its expansion into new markets in southeast Asia, Hong Kong, mainland China and the Middle East, research and development, brand awareness, equipment and infrastructure, and loan repayments.Price: 3.70, Change: -0.30, Percent Change: -7.50","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","NDAQ","IE00BKPKM429.USD","BK4588","NQmain","TQQQ","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD",".IXIC","BK4112","NVIW.SI","TSYW.SI","USAW.SI","MNQmain","IE00BGHQF748.EUR","PSQ","IE00B64PRP62.GBP","USJW.SI","SQQQ","CUPR","QLD","QID"],"gpt_icon":1},{"id":"2526564110","title":"Cuprina Prices Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2526564110","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526564110?lang=en_us&edition=fundamental","pubTime":"2025-04-10 21:10","pubTimestamp":1744290638,"startTime":"0","endTime":"0","summary":"Cuprina  said Thursday it priced its initial public offering of 3 million shares at $4 apiece, expecting to raise $12 million.The company said it granted the underwriter a 45-day option to buy up to 450,000 additional shares at the offering price.If the over-allotment is fully exercised, total gross proceeds from the offering are expected to rise to $13.8 million, Cuprina said.Cuprina said the shares are expected to begin trading Thursday on the Nasdaq stock exchange under the symbol CUPR and the offering is scheduled to close Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUPR"],"gpt_icon":0},{"id":"2526566206","title":"Cuprina Holdings (Cayman) Limited Announces Pricing of $12 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2526566206","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526566206?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:35","pubTimestamp":1744288500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA61DGXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUPR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUPR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUPR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUPR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUPR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUPR","date":"2025-07-21","current":-133.156149,"percent":0,"low":-133.156149,"twenty":-115.027772,"median":-97.872236,"eighty":-87.246568,"high":-77.893657,"avg":-100.640051,"sd":15.361425,"marketCap":162376500},"quantilePoints":[{"date":"2025-04-11","current":-84.622272,"twenty":-84.622272,"median":-84.622272,"eighty":-84.622272,"marketCap":87150000},{"date":"2025-04-17","current":-113.715976,"twenty":-101.078226,"median":-91.9774,"eighty":-89.161662,"marketCap":118920000},{"date":"2025-04-25","current":-91.46624,"twenty":-98.116219,"median":-93.732067,"eighty":-91.168717,"marketCap":95550000},{"date":"2025-05-02","current":-95.63599,"twenty":-97.370352,"median":-95.274818,"eighty":-91.140058,"marketCap":99960000},{"date":"2025-05-09","current":-97.825684,"twenty":-105.935787,"median":-96.339196,"eighty":-91.340215,"marketCap":103320000},{"date":"2025-05-16","current":-84.217807,"twenty":-100.201018,"median":-95.63599,"eighty":-90.926742,"marketCap":101244000},{"date":"2025-05-23","current":-80.581767,"twenty":-98.816165,"median":-93.626109,"eighty":-84.541379,"marketCap":97383000},{"date":"2025-05-30","current":-84.00813,"twenty":-98.268761,"median":-91.426504,"eighty":-81.435196,"marketCap":101887500},{"date":"2025-06-06","current":-96.311865,"twenty":-97.862926,"median":-91.153997,"eighty":-82.722432,"marketCap":116902500},{"date":"2025-06-13","current":-100.074473,"twenty":-99.373354,"median":-91.49587,"eighty":-83.716948,"marketCap":122050500},{"date":"2025-06-20","current":-97.809905,"twenty":-99.60706,"median":-93.000433,"eighty":-84.092001,"marketCap":118404000},{"date":"2025-06-27","current":-102.489685,"twenty":-101.494097,"median":-95.486734,"eighty":-84.379593,"marketCap":125482500},{"date":"2025-07-03","current":-120.854919,"twenty":-102.248897,"median":-96.311865,"eighty":-84.935698,"marketCap":148005000},{"date":"2025-07-11","current":-124.985474,"twenty":-106.007618,"median":-97.137822,"eighty":-86.349331,"marketCap":152295000},{"date":"2025-07-18","current":-132.572254,"twenty":-114.154514,"median":-97.825684,"eighty":-87.117803,"marketCap":160875000},{"date":"2025-07-21","current":-133.156149,"twenty":-115.027772,"median":-97.872236,"eighty":-87.246568,"marketCap":162376500}],"updateTime":1753247530634}}}